International Expo | Delta Medical Drives Clinical‑Centered Innovation at CAOS 2026

On August 16, 2026, The 17th Congress of Chinese Association of Orthopaedic Surgeons (CAOS 2026) concluded in Jinan, the City of Springs. As one of China’s premier annual academic platforms for orthopaedics, the congress brought together orthopaedic and sports‑medicine practitioners worldwide for in‑depth discussions on cutting‑edge topics including minimally‑invasive technology upgrades and standardized management of joint‑injury treatments.

Multi‑domain Collaboration · Progress Hand‑in‑Hand
At this landmark industry event, Delta Medical showcased its comprehensive sports‑medicine solution portfolio covering the shoulder, knee, hip and ankle joints. Through a full‑range product matrix and hands‑on demo sessions, Delta Medical held face‑to‑face exchanges with orthopaedic surgeons across the globe. Throughout the exhibition, Delta Medical’s booth drew constant streams of clinical physicians, who visited for product tours and hands‑on trials, creating a dynamic, high‑engagement atmosphere.
Deep‑rooted in sports‑medicine development, Delta Medical prioritizes clinical‑driven R&D. Leveraging its full‑joint product portfolio, the company has built a complete one‑stop clinical loop covering implantable devices, surgical instruments, operative equipment and orthopaedic bracing systems. Delta Medical actively collects real‑world clinical feedback from hospitals of all tiers worldwide, translates on‑site surgical pain points into actionable product‑iteration targets, and empowers clinical practice through collaborative innovation.
Innovation‑driven Excellence · Empowering Surgeons
Delta Medical highlighted its flagship products: V‑Lock™Pro All‑Suture Anchor Self‑Punching and T‑Lock™ Pro All‑Inside Meniscus Repair System. Attending surgeons performed hands‑on evaluations, assessing intraoperative handling, instrument compatibility and implant performance.
This high‑profile congress delivered profound two‑way value. At CAOS 2026, Delta Medical gained trust and recognition from global orthopaedic experts, together with abundant practical insights for future product development. Moving forward, Delta Medical will stay committed to innovation and strict quality control. It will keep refining its end‑to‑end multi‑joint solution portfolio and work alongside global orthopaedic and sports‑medicine specialists to protect patients’ joint health and help more patients regain mobility and an active lifestyle.
CAOS 2026 has come to a successful close.
Journey continues, and we look forward to future encounters.